Fig. 4

The incremental protective efficacy of pirimiphos methyl EC and CS IRS treatments on diagnostic positivity for Plasmodium falciparum malaria infection over several time periods since the last spray round began, relative to clusters that have been sprayed with either deltamethrin and/or lambdacyhalothrin (reference group), estimated exactly as described in Table 2, except that three separate models were fitted for the three different time periods since the last spray round began, and the combined pyrethroid formulations were treated as the reference group